Swiss Life Asset Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.1M Buy
2,081
+169
+9% +$78K ﹤0.01% 677
2026
Q1
$918K Buy
1,912
+332
+21% +$170K ﹤0.01% 674
2025
Q4
$887K Buy
1,580
+451
+40% +$256K ﹤0.01% 665
2025
Q3
$580K Buy
1,129
+466
+70% +$203K ﹤0.01% 682
2025
Q2
$208K Buy
+663
New +$199K ﹤0.01% 813

Other funds holding MEDP

Swiss Life Asset Management's MEDP Position: Q2 2026 in Review

Swiss Life Asset Management increased its Medpace (MEDP) stake by 8.8% in Q2 2026, buying an estimated $78K and bringing the position to 2,081 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #677.

Swiss Life Asset Management first reported a position in MEDP in Q2 2025 and has held it in 5 quarters since. 471 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Swiss Life Asset Management held 2,081 shares of Medpace worth $1.1M as of Q2 2026.
  • Swiss Life Asset Management bought 169 Medpace shares in Q2 2026, an estimated $78K.
  • Medpace made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #677 holding.
  • Swiss Life Asset Management first reported a position in Medpace in Q2 2025 and has held it in 5 quarters since.
  • 471 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.